| Application no. and date | 24156902.9 (espacenet) (Federated) (European Patent Register), 20190510 | | Patent/reg. no. and date | DK/EP 4364724, 20251126 | | Publication date | 20240508 | | Priority no. and date | US 201862669506 P, 20180510, US 201862752127 P, 20181029, US 201862769876 P, 20181120, US 201962813882 P, 20190305 | | EP pub. no. and date |
EP 4364724 20240508 | | Effective date | | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road
Tarrytown, NY 10591-6707, US | | Applicant ref. no. | V499910DK00 | | Inventor | GRAHAM, Kenneth S.,
Pleasant Valley, 12569, US,
WADHWA, Saurabh,
Nanuet, 10954, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , A61K 47/22 (2006.01) , A61K 47/26 (2006.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61P 27/02 (2006.01) | | Title | Formuleringer med høj koncentration af VEGF-receptorfusionsprotein | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
